Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease

Archives of Neurology

Volumn 57, Issue 11, 2000, Pages 1579-1583

  Finckh, Ulrich ^b   Von Der Kammer, Heinz ^b   Velden, Joachim ^b   Michel, Tiana ^a,b   Andresen, Barbara ^b   Deng, Amy ^c   Zhang, Jun ^b   Müller Thomsen, Tomas ^b   Zuchowski, Kathrin ^b   Menzer, Gunnar ^b   Mann, Ulrike ^b   Papassotiropoulos, Andreas ^d   Heun, Reinhard ^d   Zurdel, Jan ^b   Holst, Frederik ^b   Benussi, Luisa ^g   Stoppe, Gabriela ^e   Reiss, Jochen ^e   Miserez, André R ^f   Staehelin, Hannes B ^f   Rebeck, G William ^c   Hyman, Bradley T ^c   Binetti, Giuliano ^g   Hock, Christoph ^a,f   Growdon, John H ^c   Nitsch, Roger M ^a,b   more..

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d UNIVERSITY OF BONN   (Germany)

^e UNIVERSITY OF GÖTTINGEN   (Germany)

^f UNIVERSITY OF BASEL   (Switzerland)

^g Scientific Institute for Research and Patient Care   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CYSTATIN C;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOSOMAL RECESSIVE INHERITANCE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEUROLOGIC DISEASE; ONSET AGE; PRIORITY JOURNAL;

EID: 0033733370     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.57.11.1579     Document Type: Article

References (46)

1. Molecular genetics of Alzheimer's disease
2. Genetics of Alzheimer's disease
3. Alzheimer's disease: When and why?
4. Alzheimer's disease: Genetic studies and transgenic models
5. The genetics of Alzheimer disease: Current status and future prospects
6. High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes
7. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
8. Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease
9. Gene-gene interaction between interleukin-6 and alpha2-macroglobulin influences the risk for Alzheimer's disease
10. An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease
11. Alpha-2 macroglobulin gene and Alzheimer disease
12. A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease
13. Association of interleukin-1 gene polymorphisms with Alzheimer's disease
14. Association of early-onset Alzheimer's disease with an interleukin-1 alpha gene polymorphism
15. Cystatins
16. Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells
17. Human gamma-trace, a basic microprotein: Amino acid sequence and presence in the adenohypophysis
18. Developmental patterns of gene expression of 2q-secreted proteins in brain and choroid plexus
19. The cDNA structure and expression analysis of the genes for the cysteine proteinase inhibitor cystatin C and for beta 2-microglobulin in rat brain
20. Expression of cystatin C in rat, monkey and human brains
21. Cystatin C and transthyretin expression in normal and neoplastic tissues of the human brain and pituitary
22. Cystatin C, a protease inhibitor, in degenerating rat hippocampal neurons following transient forebrain ischemia
23. Cystatin C and apolipoprotein E immunoreactivities in CA1 neurons in ischemic gerbil hippocampus
24. Up-regulation of cystatin C by microglia in the rat facial nucleus following axotomy
25. Changes in distribution of cystatin C, apolipoprotein E and ferritin in rat hypothalamus after hypophysectomy
26. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease
27. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased beta-amyloidogenesis
28. Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases
29. Sstll polymorphic sites in the promoter region of the human cystatin C gene
30. An Ala/Thr variation in the coding region of the human cystatin C gene (CST3) detected as a Sstll polymorphism
31. The human cystatin C gene promoter: Functional analysis and identification of heterogeneous mRNA
32. Genetic association of CST3 with sporadic Alzheimer's disease
33. The cystatin C gene is a novel genetic risk factor for late onset Alzheimer's disease
34. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
35. Memory loss: When is it Alzheimer disease?
36. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
37. A full genome scan for late onset Alzheimer's disease
38. Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions
39. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
40. Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease
41. Lysosomal processing of amyloid precursor protein to A beta peptides: A distinct role for cathepsin S
42. The lysosomal cysteine protease, cathepsin S, is increased in Alzheimer's disease and Down syndrome brain: An immunocytochemical study
43. Distinct secretases, a cysteine protease and a serine protease, generate the C termini of amyloid beta-proteins A beta 1-40 and A beta 1-42, respectively
44. Amyloid fibrils in hereditary cerebral hemorrhage with amyloidosis of Icelandic type is a variant of gamma-trace basic protein (cystatin C)
45. Mutation in cystatin C gene causes hereditary brain haemorrhage
46. Increased body temperature accelerates aggregation of the Leu-68→Gln mutant cystatin C, the amyloid-forming protein in hereditary cystatin C amyloid angiopathy